<DOC>
	<DOCNO>NCT01403519</DOCNO>
	<brief_summary>Tau pathology tangle associate cognitive dysfunction cause neurodegeneration . AD , abundant tauopathy characterize amyloid plaque tau tangle . An abundance tau inclusion , absence amyloid deposit , define Pick 's disease ( frontotemporal lobar degeneration ) , progressive supranuclear palsy ( PSP ) , corticobasal degeneration ( CBD ) diseases include frontal atrophy associate cognitive clinical dysfunction frontal dysexecutive syndrome , progressive nonfluent aphasia semantic dementia recently review ( Gozes 2010 ) . It investigators aim follow protein expression [ per recent publication ( Marksteiner et al. , 2011 ) ] blood CSF sample tauopathies . Significance : Results establish possibility use tau protein marker early detection disease progression FTD , also comparison Alzheimer 's disease ( AD ) .</brief_summary>
	<brief_title>Innovative Biomarkers Alzheimer 's Disease Frontotemporal Dementia ( FTD ) : Preventative Personalized</brief_title>
	<detailed_description>Assessing biomarkers Alzheimer 's disease frontotemporal dementia 1 . Specific Aims To enhance field biomarker recognition facilitate preventative personalized medicine pose follow question , Israeli patient population present similar plasma protein profile describe population ( Marksteiner et al. , 2011 ) . Studies carry RNA transcript quantification , quantitative real time polymerase chain reaction ( blood cell CSF ) immunochemical detection protein level ( CSF serum ) . 2 . Methods : Lymphocytes : Human lymphocytes isolate 10 ml venous blood use Ficoll Paque method ( de Rock Taylor 1977 ; McCauley Hartmann , 1982 ) , RNA extraction determination shall follow-up method describe manuscript ( Dresner et al. , 2011 ) . Blood plasma serum prepare outlined www.peoimmune.com . Protein quantitation carry use Tri reagent ( Sigma ) allow simultaneous preparation RNA , DNA protein plasma immunodepletion albumin depletion kit Sigma . Protein quantification : carry cellular protein also plasma protein SDS-polyacrylamide gel electrophoresis , follow western analysis . CSF sample collect spinal needle insert L4-L5 L3-L4 vertebral space subject lateral decubitus position . One ml CSF derive patient immediately immersed ice , subsequent maintenance -70 degree C ( dry ice ship ) time assay . Half ml CSF sample concentrate lyophilization Speed-Vac ( Holten , Gydevang , Denmark ) 0.1ml . CSF protein immunoblotting perform use similar methodology describe [ see also ( Kozlovsky et al. , 2004 ) ] . Protein expression analyze western blot ( Shiryaev et al. , 2010 ) . Number patient : We estimate 30 patient Alzheimer 's disease , 20 patient frontotemporal dementia 20 control include . Professor Aharon-Peretz evaluate patient suspect Alzheimer 's disease frontotemporal dementia include patient various disease stage stratify manner ( mild , moderate severe ) . All patient sign informed consent form , per Helsinki guideline . Clinical evaluation include : physical neurological evaluation . All patient ask donate 50 ml blood select patient undergo lumber puncture . The lumber puncture perform neurological work . Professor Gozes coordinate scientific aspect study . Study coordinator : Scientific : Professor Illana Gozes , PhD , The Lily Avraham Gildor Chair Investigation Growth Factors ; Director , The Adams Super Center Brain Studies , Tel Aviv University : igozes @ post.tau.ac.il Clinical material : Professor Judith Aharon-Peretz , MD , Head `` Cognitive Neurology Unit '' Rambam Rambam-Health Care Campus , Haifa , Israel</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<criteria>Minimal cognitive impairment ( MCI ) Alzheimer 's disease ( AD ) patient , men woman , age 4580 ask participate present study . MCI diagnose cognitive evaluation patient score &lt; 1.5 SD memory test demented . AD diagnose accord NINCDSADRDA research criterion . Patients stratified age cognitive ( dementia ) status . Disease severity AD : mild moderate ( MMSE &gt; 16 ) AD . Frontotemporal dementia : patient clinical diagnosis frontotemporal dementia [ behavioral variant ( bv ) FTD , progressive nonfluent aphasia ( PNFA ) , semantic dementia ] relate syndrome corticobasal syndrome ( CBS ) progressive supranuclear palsy ( PSP ) include . Inclusion criterion ( control ) : men woman , age 4580 , willing participate study donate blood sample . ( patient control ) : 1 . Subjects unable/unwilling sign inform consent . 2 . Patients associated medical condition : alcoholism , immune disease end stage medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>